Retour sur lavenir.net
   KBC ANCORA 83.100 € (+1,22 %)     KBC 119.700 € (+0,34 %)     AB INBEV 71.220 € (-1,98 %)     ARGENX SE 793.600 € (-2,19 %)     ECONOCOM GROUP 1.480 € (-1,66 %)     SHURGARD 26.300 € (+2,73 %)     VGP 84.100 € (-0,12 %)     WERELDHAVE BELGIUM 52.400 € (0,00 %)     QRF 10.350 € (-0,48 %)     CENERGY 21.920 € (-4,86 %)     MELEXIS 78.350 € (+0,32 %)     ELIA GROUP 135.400 € (-3,15 %)     EXMAR 11.250 € (-0,88 %)     XIOR 26.400 € (+0,38 %)     AZELIS GROUP 9.395 € (+0,97 %)     ACKERMANS V.HAAREN 278.800 € (-2,45 %)     BIOTALYS 3.105 € (+0,32 %)     CFE 13.000 € (-1,52 %)     ACCENTIS 0.026 € (0,00 %)     BEKAERT 39.350 € (+0,77 %)     VAN DE VELDE 30.100 € (-0,33 %)     HOME INVEST BE. 19.120 € (-0,10 %)     AGFA-GEVAERT 0.422 € (-1,40 %)     MATERIALISE 6.550 € (+0,77 %)     TUBIZE-FIN 223.600 € (-3,20 %)     BPOST 1.566 € (+1,03 %)     ORANGE BELGIUM 21.500 € (0,00 %)     ONWARD MEDICAL 2.550 € (+1,39 %)     CARE PROPERTY INV. 12.580 € (-0,16 %)     AEDIFICA 70.350 € (-0,35 %)     WDP 21.980 € (-0,36 %)     COLRUYT 35.840 € (-0,33 %)     EVS 27.800 € (+1,65 %)     RECTICEL 10.880 € (-0,73 %)     DEME GROUP 171.400 € (-2,06 %)     CIE BOIS SAUVAGE 305.000 € (-0,65 %)     FAGRON 24.000 € (-0,41 %)     BANQUP GROUP 2.060 € (-3,29 %)     PROXIMUS 5.775 € (-1,28 %)     BREDERODE 104.400 € (-0,19 %)     QRF(SUB)C15 0.035 € (-12,50 %)     FLUXYS BELGIUM D 19.450 € (+0,78 %)     GBL 79.550 € (-0,19 %)     ONTEX GROUP 2.430 € (+0,62 %)     TINC 11.380 € (-0,52 %)     LOTUS BAKERIES 11 520.000 € (-0,86 %)     RETAIL ESTATES 68.300 € (-0,58 %)     UCB 257.900 € (-1,56 %)     CMB.TECH 12.500 € (+0,81 %)     CAMPINE 221.000 € (+1,84 %)     TESSENDERLO 20.750 € (+7,29 %)     SIPEF 91.000 € (-1,19 %)     BELYSSE GROUP 0.530 € (-3,64 %)     UMICORE 20.660 € (+2,08 %)     MONTEA 66.400 € (-0,75 %)     VASTNED 29.500 € (-0,17 %)     ENERGYVISION 14.800 € (+3,93 %)     BARCO 8.420 € (+0,36 %)     SOFINA 228.200 € (+2,52 %)     IBA 17.500 € (+3,55 %)  
   WORLDLINE 10.814 € (+5,19 %)     EUTELSAT COMMUNIC. 2.499 € (+3,56 %)     TOTALENERGIES 65.920 € (-3,10 %)     HERIGE 21.100 € (+2,93 %)     CAPITAL B 0.425 € (+5,60 %)     SAFRAN 349.900 € (+1,42 %)     BNP PARIBAS ACT.A 101.160 € (-0,96 %)     SOCIETE GENERALE 76.850 € (-0,67 %)     MAROC TELECOM 8.800 € (-0,68 %)     PHARMING GROUP 1.199 € (-0,25 %)     SANOFI 73.050 € (-2,70 %)     PIERRE VACANCES 1.816 € (-0,22 %)     RENAULT 26.280 € (+4,78 %)     SHELL PLC 33.595 € (-1,38 %)     DASSAULT SYSTEMES 18.385 € (+3,20 %)     WOLTERS KLUWER 57.200 € (+1,35 %)     NN GROUP 75.820 € (-1,10 %)     ARCELORMITTAL SA 52.040 € (-1,25 %)     ENGIE 26.550 € (-3,77 %)     ASML HOLDING 1 641.600 € (-4,64 %)     AEGON 7.578 € (+1,88 %)     ING GROEP N.V. 27.640 € (-0,11 %)     FLOW TRADERS 25.820 € (0,00 %)     VINCI 124.300 € (-2,74 %)     VIVENDI SE 2.216 € (+2,59 %)     VIRIDIEN 77.300 € (-7,76 %)     ALTAREA 96.700 € (-1,02 %)     BOUYGUES 47.590 € (-2,50 %)     ASM INTERNATIONAL 993.000 € (-0,75 %)     SCHNEIDER ELECTRIC 276.650 € (-3,07 %)     ESSILORLUXOTTICA 173.000 € (+5,46 %)     BUREAU VERITAS 26.700 € (-0,30 %)     LVMH 481.000 € (-0,64 %)     CARREFOUR 15.700 € (-3,38 %)     BOLLORE 4.080 € (+0,59 %)     GROUPE GUILLIN 22.600 € (0,00 %)     Coca-ColaEuropacif 92.600 € (+5,47 %)     AIRBUS 198.220 € (+1,89 %)     THALES 229.400 € (+2,05 %)     CREDIT AGRICOLE 17.480 € (-0,65 %)     PERNOD RICARD 61.980 € (-2,94 %)     CAPGEMINI 90.720 € (+3,14 %)     EURONEXT 140.900 € (+0,64 %)     KERING 245.750 € (-0,63 %)     AXA 43.500 € (-0,80 %)     UNIBAIL-RODAMCO-WE 101.100 € (-1,32 %)     PUBLICIS GROUPE SA 84.460 € (+2,10 %)     HERMES INTL 1 595.000 € (-0,19 %)     L'OREAL 380.350 € (-0,86 %)     ORANGE 15.765 € (-4,48 %)     DANONE 72.200 € (+0,64 %)     SAINT GOBAIN 78.460 € (-0,88 %)     STMICROELECTRONICS 62.370 € (-3,29 %)     NEXITY 7.825 € (-0,25 %)     HEINEKEN 74.480 € (+1,20 %)     VALEO 12.635 € (-1,40 %)     PHILIPS KON 23.960 € (+0,84 %)     RELX 27.680 € (+0,36 %)     FUGRO 9.525 € (+0,79 %)     ABN AMRO BANK N.V. 37.030 € (-0,40 %)  
News Réglementées
21/03/2023 13:30

CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website

CALGARY, AB / ACCESSWIRE / March 21, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has finalized the purchase of LTB Management LLC (LTB), an e-commerce financial platform company utilized to support online sales for a variety of products.

With the closing, the company will not only begin to immediately book revenue, but also will be able to provide cutting-edge technology for online marketing, e-commerce, and advanced inventory management. In addition, the platform will also CannapharmaRx with international sales and marketing.

The company has recently unveiled an enhanced website that will be able to provide keen insight on company products, enable e-commerce marketing, and provide investors with important information about the company. Please visit https://cannapharmarx.com/ to view.

"We are confident about the current direction of the company. We have added a revenue stream and are close to completing our first harvest. We expect to produce and deliver at an annual run rate of nearly $30 million beginning in April," stated Chief Executive Officer, Dominic Colvin.

About CannapharmaRx, Inc.

CannapharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. CPMD is in discussion with other companies regarding potential acquisitions. CannapharmaRx's business strategy is to become a leader in high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. CannapharmaRx is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.

Safe Harbor Statement

Cautionary Note Regarding Forward-Looking Information or Statements

This press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations, or beliefs of future performance, are 'forward-looking information or statements.' Forward-looking information or statements can be identified by the use of words such as 'plans,' 'expects,' or 'does not expect,' 'is expected,' 'estimates,' 'intends,' 'anticipates,' or 'does not anticipate,' or 'believes,' or variations of such words and phrases or statements that certain actions, events or results 'may,' 'could,' 'would,' 'might' or 'will' be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Management of CannapharmaRx has made numerous assumptions, including, among other things, assumptions about general business and economic conditions. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results, events, or developments to be materially different from any future results, events, or developments expressed or implied by such forward-looking information or statements. Readers are cautioned not to place undue reliance on such forward-looking information or statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. CannapharmaRx assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information, or for any other reason except as required by law.

Brokers and Analysts
Chesapeake Group
410-825-3930
info@chesapeakegp.com

SOURCE: CannaPharmaRx, Inc.



View source version on accesswire.com:
https://www.accesswire.com/744799/CannaPharmRx-Inc-Completes-Purchase-of-LTB-Management-an-E-Commerce-and-Financial-Platform-Company-and-Launches-New-Corporate-Website

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière